Abstract:With our current appreciation of the complexity of eukaryotic transcription, whose dysregulation drives diseases including cancer, it is becoming apparent that identification of key events coordinating multiple aspects of transcriptional regulation is of special importance. To elucidate how assembly of RNA polymerase II (Pol II) with Mediator complex preinitiation complexes (PICs) and formation of transcription-permissive 3D chromatin organization are coordinated, we studied MED1, a representative subunit of the Mediator complex that acts to establish functional preinitiation complexes (PICs) that forms biomolecular condensates through an intrinsically disordered region (IDR) to facilitate transcription , and is implicated in the function of estrogen receptor α (hereafter ER) in ER-positive breast cancer (ER BC) cells . We found that MED1 is acetylated at 6 lysines in its IDR and, further, that MCF7 ER BC cells in which endogenous MED1 is replaced by an ectopic 6KR (non-acetylatable) mutant (6KR cells) exhibit enhanced cell growth and elevated expression of MED1-dependent genes. These results indicate an enhanced function of 6KR MED1 that may be attributed to two mechanisms: (1) reorganized PIC assembly, as indicated by increased MED1 and Pol II, decreased MED17, and equivalent ERα occupancies on chromatin, particularly at active enhancers and promoters; (2) sub-TAD chromatin unfolding, as revealed by HiCAR (Hi-C on accessible regulatory DNA) analyses. Furthermore, in vitro assays demonstrate distinct physio-chemical properties of liquid-liquid phase separation (LLPS) for 6KR versus 6KQ MED1 IDRs, and for non-acetylated versus CBP-acetylated WT MED1 IDR fragments. Related, Pol II CTD heptads are sequestered in 6KR and control WT MED1 IDR condensates, but not 6KQ and CBP-acetylated WT MED1 IDR condensates. These findings, in conjunction with recent reports of PIC structures , indicate that MED1 coordinates reorganization of the PIC machinery and the rewiring of regional chromatin organization through acetylation of its IDR. This study leads to an understanding of how the transition in phase behavior of a transcription cofactor acts as a mechanistic hub integrating linear and spatial chromatin functions to support gene expression, and have potential therapeutic implications for diseases involving MED1/Mediator-mediated transcription control.

Key Roles for Med1 Lxxll Motifs in Pubertal Mammary Gland Development and Luminal-Cell Differentiation

An Autoregulatory Enhancer Controls Mammary-Specific Stat5 Functions

HER2-Driven Breast Tumorigenesis Relies Upon Interactions of the Estrogen Receptor with Coactivator MED1.

MED20 is Essential for Early Embryogenesis and Regulates NANOG Expression

Functional Cooperation Between Co-Amplified Genes Promotes Aggressive Phenotypes of HER2-positive Breast Cancer.

Mediator MED23 Plays Opposing Roles in Directing Smooth Muscle Cell and Adipocyte Differentiation.

MED1 IDR acetylation reorganizes the transcription preinitiation complex, rewires 3D chromatin interactions and reprograms gene expression

The essential role of MED27 in stabilizing the mediator complex for cardiac development and function

Arginine and Glutamate-rich 1 (ARGLU1) Interacts with Mediator Subunit 1 (MED1) and is Required for Estrogen Receptor-mediated Gene Transcription and Breast Cancer Cell Growth

The Characterization of Mediator 12 and 13 As Conditional Positive Gene Regulators in Arabidopsis

Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer

Molecular Mechanism for the Potentiation of the Transcriptional Activity of Human Liver Receptor Homolog 1 by Steroid Receptor Coactivator-1

The Mediator Subunit MED23 Couples H2B Mono‐ubiquitination to Transcriptional Control and Cell Fate Determination

JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex

The Notch Coactivator, Maml1, Functions As A Novel Coactivator For Mef2c-Mediated Transcription And Is Required For Normal Myogenesis

Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice

Mediator Med23 Regulates Basal Transcription In Vivo Via An Interaction With P-Tefb

The Mediator Med23 controls a transcriptional switch for muscle stem cell proliferation and differentiation in muscle regeneration

Tip30 Controls Differentiation of Murine Mammary Luminal Progenitor to Estrogen Receptor-Positive Luminal Cell Through Regulating FoxA1 Expression.

Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α

The role of Med15 sequence features in transcription factor interactions